Search clinical trials for: 14-247

Total 7365 results

Memorial Sloan Kettering Cancer Center
New York University; The City College of New York; New York State Department...

Completed

DRIIVE (Data and Research on Interventions to Improve the Vehicular Environment)

Vehicular Environment

United States
Healthpoint

Terminated

A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers (MOA 034)

Venous Leg Ulcers

United States
Healthpoint

Completed

Study of Survival Duration for Donor Skin Cells in Skin Biopsy Wounds

Normal Female Volunteers

United States
Healthpoint

Unknown

Safety Study Providing 12 Months Follow-up From First Exposure to HP802-247 in Subjects With Venous Leg Ulcer

Venous Leg Ulcer

United States, Canada
Healthpoint

Terminated

Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers

Ulcer | Venous Ulcer | Venous Stasis Ulcer

Germany, Poland, Belgium, Czech Republic, Hungary
University Hospital, Clermont-Ferrand
World Rugby Research Unit

Unknown

Blood Biomarkers for the Management of Concussion in Professional Rugby Players (RUGBYPROS100B)

Concussion | Professional TOP14 Rugby Players

France
University of Malaya

Unknown

Comparing Clinical Application of Innovatedly Made Transpalatal Arch (TPA) From 3D Reconstructed Model and Conventionally Made TPA

Transpalatal Arch (TPA) | Oral Health Related Quality of Life (OHRQoL) | Oral Health Impact Profile Short Version 14 (OHIP 14) | Orthodontic Pain | Three Dimensional (3D) Orthodontic Device

Malaysia
The Chemo-Sero-Therapeutic Research Institute

Completed

A Study of Anti-HIV Monoclonal Antibody KD-247

HIV Infections

United States
Healthpoint

Completed

Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2

Venous Leg Ulcers

United States, Canada, Puerto Rico
Healthpoint

Withdrawn

A Pilot Study of HP802-247 in Dystrophic Epidermolysis Bullosa

Dystrophic Epidermolysis Bullosa
Atlantic Health System

Unknown

Trial of Compassionate Use of hp802-247 to Treat Venous Leg Ulcers in Subjects Who Have Failed Multiple Other Healing Technologies

Venous Leg Ulcer

United States
Healthpoint
Smith & Nephew, Inc.

Completed

Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers

Venous Leg Ulcers

United States, Canada
Chungbuk National University Hospital
Merck KGaA, Darmstadt, Germany

Recruiting

Tepotinib in Solid Tumors Harboring MET Alterations

Solid Tumor | MET Amplification | MET Exon 14 Skipping Mutation

Korea, Republic of
Healthpoint

Completed

Dose Finding Study of HP802-247 in Venous Leg Ulcers

Venous Leg Ulcer | Venous Stasis Ulcers

United States, Canada
State Budgetary Healthcare Institution, National...

Recruiting

First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1) (HL-Russia-1)

Hodgkin Lymphoma, Adult

Russian Federation
Rennes University Hospital
LTSI-INSERM U1099; CIC-IT 14-14

Completed

Sensors for HEalth Recording and Physical Activity Monitoring (SHERPAM)

Physical Activity

France
Memorial Sloan Kettering Cancer Center

Recruiting

Germ Cell Tumor and Testicular Tumor DNA Registry

Germ Cell Tumor | Testicular Tumor

United States
International Centre for Diarrhoeal Disease Research...

Completed

Immunogenicity of SA 14-14-2 JE Vaccine

Healthy Infants

Bangladesh
Memorial Sloan Kettering Cancer Center
MethylGene Inc.

Terminated

Study of Mocetinostat in Selected Patients With Mutations of Acetyltransferase Genes in Relapsed and Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

Lymphoma | Relapsed and Refractory | Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

United States
Memorial Sloan Kettering Cancer Center
AstraZeneca; MedImmune LLC

Completed

Evaluate the Efficacy of MEDI4736 in Immunological Subsets of Advanced Colorectal Cancer

Advanced Colorectal Cancer

United States
Novan, Inc.
Novella Clinical

Completed

A Study Assessing the PK, PD, Safety, and Tolerability of SB414 in Psoriasis

Psoriasis

United States
Columbia University
Pfizer

Completed

Crizotinib in High-Risk Uveal Melanoma Following Definitive Therapy

Uveal Melanoma

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Evaluation of Treatment Response Using Multiparametric MRI After Prostate Radiotherapy

Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center

Completed

Nintedanib in Patients With Advanced Esophagogastric Cancer

Esophagogastric Adenocarcinoma

United States
Memorial Sloan Kettering Cancer Center
The City College of New York

Completed

Yoga Practice for Breast or Ovarian Cancer Patients

Breast Cancer | Ovarian Cancer

United States
Memorial Sloan Kettering Cancer Center
Fordham University

Active, not recruiting

Identifying and Measuring Depression in Older Cancer Patients

Older Cancer Patients

United States
Memorial Sloan Kettering Cancer Center
Ohio State University; Pharmacyclics LLC.; Janssen Biotech, Inc.

Completed

Study of Ibrutinib in Relapsed and Refractory T-cell Lymphoma

T-cell Lymphoma | Relapsed and Refractory T-cell Lymphoma

United States
Memorial Sloan Kettering Cancer Center

Completed

Predictive MRI Metrics for Tumor Aggressiveness in Papillary Thyroid Cancer

Papillary Thyroid Cancer

United States
Healthpoint

Completed

Healing Effects of HP802-247 Versus Antibiotic Ointment in Mohs Micrographic Surgery Patients

Non-melanoma Skin Cancer

United States
University Hospital, Montpellier

Completed

Accuracy of eDiagEPU, a Medical Computerized Tool for EPU (eDiagEPU)

Pregnant Women Less Than 14 Weeks of Gestation

France
Memorial Sloan Kettering Cancer Center
Novartis

Completed

Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)

Lymphoma | Primary Central Nervous System Lymphoma | Recurrent/Refractory Secondary Central Nervous System Lymphoma

United States
Healthpoint

Completed

Safety Follow-Up to HP 802-247-09-015

Venous Leg Ulcer | Venous Stasis Ulcer

United States, Canada
Ondokuz Mayıs University

Completed

Oral Health Related Quality of Life and Periodontal Diseases

Periodontal Diseases
Memorial Sloan Kettering Cancer Center
Weizmann Institute of Science; Cold Spring Harbor Laboratory

Completed

Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection

Pancreatic Cancer

United States
Misr International University

Completed

the Effect of High Dose Ascorbic Acid on Critically Ill Patients With ARDS

Acute Respiratory Distress

Egypt
Memorial Sloan Kettering Cancer Center
Novartis Pharmaceuticals; Incyte Corporation

Active, not recruiting

Adding Ruxolitinib to a Combination of Dasatinib Plus Dexamethasone in Remission Induction Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients Aged 40 Years or Older

Acute Lymphoblastic Leukemia

United States
Memorial Sloan Kettering Cancer Center

Completed

Carvedilol for the Prevention of Anthracycline/Anti-HER2 Therapy Associated Cardiotoxicity Among Women With HER2-Positive Breast Cancer Using Myocardial Strain Imaging for Early Risk Stratification

Breast Cancer

United States
Al-Azhar University

Completed

14-3-3η Protein, Disease Activity and Bone Mineral Density, in Female Patients With Rheumatoid Arthritis

Rheumatoid Arthritis | Osteoporosis

Egypt
Shin Nippon Biomedical Laboratories, Ltd.

Completed

Phase 2 Study of Efficacy, Tolerability, and Safety of Intranasal Granisetron for Chemo-Induced Nausea and Vomiting

Chemotherapy-Induced Nausea and Vomiting

United States
Memorial Sloan Kettering Cancer Center

Completed

Evaluate the Response to 2 Induction Courses (12 Intravesical Instillations) of Bacillus Calmette-Guérin (BCG) for High Risk Superficial Bladder Cancer

Bladder Cancer | High Risk Superficial

United States
Memorial Sloan Kettering Cancer Center
Hoffmann-La Roche; Genentech, Inc.; Hartford HealthCare

Active, not recruiting

Gemcitabine, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer After Prior Trastuzumab/Pertuzumab, or Pertuzumab Based Therapy

Metastatic HER2-Positive Breast Cancer

United States
Memorial Sloan Kettering Cancer Center

Completed

Whole Lung IMRT in Children and Adults With Synovial Sarcoma and Lung Metastases

Synovial Sarcoma | Single or Multiple Lung Metastases

United States
Atrium Medical Corporation

Terminated

COronary Native Artery First in Man Investigation of ISA 247 Elution to Prevent Restenotic Mechanisms (CONFIRM 1) (CONFIRM 1)

Coronary Artery Disease

Belgium
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Local Control With Reduced-dose Radiotherapy for High-Risk Neuroblastoma

Neuroblastoma

United States
Memorial Sloan Kettering Cancer Center

Completed

Assessing Insulin Sensitivity and Diabetes Risk in Childhood Cancer Survivors Treated With Abdominal Irradiation

Childhood Cancer Survivors Treated With Abdominal Radiation

United States
Government College University Faisalabad

Completed

Effectiveness of Routine Physical Therapy With and Without Thoracic Mobility Exercises in Chronic Neck Pain

Neck Pain

Pakistan
Memorial Sloan Kettering Cancer Center

Completed

Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate Cancer

Prostate Cancer

United States
Hanmi Pharmaceutical Company Limited

Completed

Efficacy and Safety of Amlodipine and Losartan in Patients With Essential Hypertension

Hypertension

Korea, Republic of
Memorial Sloan Kettering Cancer Center
University of Pittsburgh; Ohio State University

Recruiting

Genomic Predictors of Papillary Microcarcinoma Disease Progression

Papillary Microcarcinoma

United States
Memorial Sloan Kettering Cancer Center
Lynn Cancer Institute

Active, not recruiting

Electronic Skin Surface Brachytherapy for Cutaneous Basal Cell and Squamous Cell Carcinoma

Squamous Cell Carcinoma | Cutaneous Basal Cell

United States

Search clinical trials for: 14-247

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations